Target intelligence / Profile preview

Protein-L-isoaspartate O-methyltransferase domain containing 1 pseudogene 2 (PCMTD1P2)

Target
PCMTD1P2
Molecular classification
Pseudogene, Long non-coding RNA (if transcribed)
01

Overview

Protein-L-isoaspartate O-methyltransferase domain containing 1 pseudogene 2 (PCMTD1P2) is a pseudogene, meaning it is a DNA sequence resembling a gene but generally considered non-functional for protein coding due to inactivating mutations. Pseudogenes may have regulatory functions at the RNA level, such as acting as decoys for microRNAs or regulating the expression of protein-coding relatives through RNA-based mechanisms[1][2]. However, there is no evidence that PCMTD1P2 itself is functional in this way, and it is not recognized as a receptor, enzyme, transporter, or therapeutic target. Most databases and scientific literature classify it as a non-functional genomic element with no established role in pathology or as a drug target. It should not be regarded as a conventional molecular target.

Other names
No common aliases found; alternative names may include various expanded forms or identifiers referring to its nature as a pseudogene of the PCMTD1 domain.
02

Mechanism of action

Not applicable; not known or predicted to directly interact with drugs or function as a therapeutic target

03

Biological functions

Possible regulatory roles at the RNA level, can act as a microRNA decoy, competing endogenous RNA (ceRNA) or “sponge” (potential, not confirmed for PCMTD1P2 specifically)Other (no evidence for protein coding or direct canonical biochemical function)
04

Disease associations

Other (no direct disease association; however, some pseudogenes in general are implicated in regulation of cancer, metabolism, or other cellular processes)

Beyond the preview

Go deeper on Protein-L-isoaspartate O-methyltransferase domain containing 1 pseudogene 2 (PCMTD1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein-L-isoaspartate O-methyltransferase domain containing 1 pseudogene 2 (PCMTD1P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call